NASDAQ$BTTC

Black Titan Corp · Q3 2024 earnings

Q3 2024 earnings · Reported Jan 3, 2025 (2 years ago) · Investor relations

Jan 3Sep 30, 2024

Total Revenue

$0.00

Previous: $4K-100.0%

EPS (adj)

-$0.83

Previous: -$0.40-107.5%

Capital Expenditures

$0.00

Previous: $0.00

Free Cash Flow

-$693K

Previous: -$1.84M+62.2%

Net Income

-$763K

Previous: -$338K-125.7%

Operating Income

-$754K

Previous: -$2.06M+63.4%

Gross Profit

$0.00

Previous: -$23K+100.0%

Cash & Equivalents

$3.4M

Previous: $8.11M-58.1%

Total Assets

$3.6M

Previous: $10M-64.0%

R&D Expense

$0.00

Previous: $424K-100.0%

Titan Pharmaceuticals · Revenue · Quarterly

Q3 2024-100%vs Q3 2023

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation